|
The National SARS Prevention and
Treatment S&T Group has listed screening
Chinese traditional medicines for SARS applications as a
priority objective in its research activities. As a part of
the special project of Key Technologies against SARS and
Associated Products, the efforts
have produced conditional
results.
The traditional medicine screening
team is headed by the Chinese Academy of Traditional
Medicines with the involvement of the Beijing University of
Chinese Traditional Medicines, the Institute of Pharmacy
under the Chinese Academy of Medical Sciences and the
Institute of Pharmacy subordinated to the Chinese Military
Academy of Medical Sciences. With the aim of alleviating
illness, stabilizing symptoms, lowering
mortality, and being closely in line with clinical
practices, the group has paid particular attention to the
major pathological links that affect the development of
disease and result in death. These include high fever,
perspiration, fiber breakdown and organ failures. The
Pharmacy has screened 30 Chinese traditional medicines that
have already been approved by the State authorities for
clinical applications and have begun their trial
applications in clinical SARS treatment in Guangzhou and
Beijing. These traditional medicines have been tested in
animal models bearing similar clinical pathological
links.
Within the short period of 17 days, the
group has completed 118 rounds of
internal and external experiments, prepared 5,000
pathological slices of organ specimens and conducted
biological - indictor testing nearly 6,000 times. On the
basis of statistic analysis, the group has preliminarily
screened out eight Chinese traditional medicines thought
able to alleviate clinical symptoms in different
pathological links of SARS disease. The screening efforts
have produced effective scientific data to support the
applications of Chinese traditional medicines in SARS
clinical treatment, as well as new scientific evidence for
the optimal applications of traditional medicines.
|
Suggest To A Friend